Caris Life Sciences
NASDAQ: CAIIncorporated in Texas · 3 known investors
Caris Lifesciences operates a precision oncology platform that analyzes DNA, RNA and proteins across tissue and blood to profile a patient's cancer and match treatments and clinical trials. It offers comprehensive molecular profiling tests, including the Caris Detect multi-cancer early detection blood test, for cancer patients and physicians.
Founders & leadership
DD
David Dean HalbertChairman, Founder and CEO